XML 20 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
COMMON STOCK
CAPITAL SURPLUS
ACCUMULATED OTHER COMPREHENSIVE INCOME
RETAINED EARNINGS
Balance at beginning of period, (in shares) at Dec. 31, 2012   139,439      
Balance at beginning of period at Dec. 31, 2012   $ 139 $ 798,093 $ 43,779 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net issuances of restricted stock, (in shares)   1,091      
Net issuances of restricted stock   $ 1 (1)    
Repurchases of common stock, (in shares)   (4,461)      
Repurchases of common stock   $ (4)     (162,029)
Exercises of stock options, (in shares) 1,397 1,397      
Exercises of stock options   $ 1 33,285    
Cash dividends     (12,256)   (76,851)
Stock-based compensation expense     38,867    
Tax impact of equity incentive plans     10,132    
Foreign currency translation adjustments, net of tax $ (5,708)     (5,708)  
Net income $ 252,195       252,195
Balance at end of period, (in shares) at Dec. 31, 2013   137,466      
Balance at end of period at Dec. 31, 2013   $ 137 868,120 38,071 13,315
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net issuances of restricted stock, (in shares)   938      
Net issuances of restricted stock   $ 1 (1)    
Repurchases of common stock, (in shares)   (3,798)      
Repurchases of common stock   $ (4)     (183,969)
Exercises of stock options, (in shares) 528 528      
Exercises of stock options   $ 1 14,323    
Cash dividends     0   (98,438)
Stock-based compensation expense     40,821    
Tax impact of equity incentive plans     4,894    
Foreign currency translation adjustments, net of tax $ (23,341)     (23,341)  
Net income 305,928       305,928
Balance at end of period, (in shares) at Dec. 31, 2014   135,134      
Balance at end of period at Dec. 31, 2014 $ 979,858 $ 135 928,157 14,730 36,836
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net issuances of restricted stock, (in shares)   785      
Net issuances of restricted stock   $ 1 (1)    
Repurchases of common stock, (in shares)   (4,817)      
Repurchases of common stock   $ (5)     (252,916)
Exercises of stock options, (in shares) 54 54      
Exercises of stock options   $ 0 1,529    
Cash dividends     0   (107,249)
Stock-based compensation expense     41,292    
Tax impact of equity incentive plans     8,500    
Foreign currency translation adjustments, net of tax $ (25,024)     (25,024)  
Net income 357,796       357,796
Balance at end of period, (in shares) at Dec. 31, 2015   131,156      
Balance at end of period at Dec. 31, 2015 $ 1,003,781 $ 131 $ 979,477 $ (10,294) $ 34,467